Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.

American journal of clinical pathology - 3 Sept 2024

Crane Genevieve M, Geyer Julia T, Thakral Beenu, Wang Sa A, Wool Geoffrey D, Li Ke David, Davis Adam R, Boiocchi Leonardo, Bosler David, Bueso-Ramos Carlos E, Arber Daniel A, George Tracy I, Bagg Adam, Hasserjian Robert P, Orazi Attilio, Hsi Eric D, Rogers Heesun J

Abstract excerpt

OBJECTIVES: Myeloproliferative neoplasm, unclassifiable (MPN-U, revised to MPN, not otherwise specified in the fifth edition of the World Health Organization classification) is a heterogeneous category of primary marrow disorders with clinical, morphologic, and/or molecular features that preclude classification as a more specific MPN subtype due to stage at diagnosis, overlapping features between MPN subtypes, or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Bone Marrow

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Prognosis

Share to Young Adult

Source

Identifiers

PMID: 38597584
DOI: 10.1093/ajcp/aqae033

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study.PMID 38597584Read ↗

Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the 'unclassifiable'.Semantic proximity Read ↗

Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT.Semantic proximity Read ↗

Advances in molecular evaluation of myeloproliferative neoplasms.Semantic proximity Read ↗

Molecular diagnostic criteria of myeloproliferative neoplasms.Semantic proximity Read ↗

Myeloproliferative neoplasms: updates on molecular pathophysiology, diagnosis and treatment strategies.Semantic proximity Read ↗

Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.Semantic proximity Read ↗

Impact of integrated genetic information on diagnosis and prognostication for myeloproliferative neoplasms in the next-generation sequencing eraSemantic proximity Read ↗

Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms.Semantic proximity Read ↗

Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing EraSemantic proximity Read ↗

Guidelines for the management of myeloproliferative neoplasms.Semantic proximity Read ↗

Myeloproliferative neoplasms 2012: the John M. Bennett 80th birthday anniversary lecture.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.